Gibson Lab
Impact

You are here

News

Showing 1 - 22 of 22 total
Grace's photo and quote "I am hoping this conference will provide me with the tools to confront challenges and make a true difference in my community as well as spark action on a more global scale alongside a new network of global leaders.”
NEWS: 
Article
Grace Hansen, a summer undergraduate student at Burke Neurological Institute (BNI), recently won a scholarship to attend the Youth Assembly Conference in New York City in August. Grace is one of five people from the United States chosen for this scholarship.
Lab members of the Gibson Lab
NEWS: 
Press Release
The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild cognitive impairment (MCI).
Dr. Beal's photo
NEWS: 
Article

Burke Neurological Institute (BNI) is deeply saddened by the passing of an incredibly kind and thoughtful colleague, Dr. M. Flint Beal. As one of the greatest clinician-scientists of his generation, Dr.

Gibson Team in the Lab
NEWS: 
Article
Today, scientists still do not know the cause of Alzheimer’s disease (AD), yet decades of research advancements give hope to the possibility of slowing down early-onset of AD. Benfotiamine, a therapeutic drug that raises blood vitamin B1, levels very high, was recently tested as a pilot clinical study conducted by the Gibson Lab at the Burke Neurological Institute.
Gibson Team in the Lab
NEWS: 
In the Media
Media Outlet: 
CNN Health
Benfotiamine and Cognitive Decline in Alzheimer's Disease, a small exploratory clinical trial, conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute is listed in CNN Health’s article on ”Top 2020 health stories you may have missed because of Covid-19” under Advances in Alzheimer’s.
Photo of Gibson Lab
NEWS: 
Article
A small exploratory clinical trial conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute in collaboration with physicians at the Burke Rehabilitation Hospital, suggests that Benfotiamine is safe and potentially efficacious in improving cognitive outcomes among people living with Mild Cognitive Impairment and mild Alzheimer’s disease (AD).

2019 - A Year in Photos

NEWS: 
Article
Burke Neurological Institute is pleased to share our highlights and impacts achieved during 2019. Together, we renew hope to those living with neurological disabilities by helping people to see, remember, talk, write, and walk again. Enjoy these accomplishments from 2019 as we look forward to a bright 2020!

Happy Holidays from Burke Neurological Institute

NEWS: 
Video
Burke Neurological Institute is very grateful to our Board of Trustees, faculty, staff, patients, families, and friends. Thank you for bringing our mission to life and for supporting our efforts to advance the Science that Hope Demands!
Photo of Gibson lab at Jiaxing University
NEWS: 
Social Media

Dr. Gary Gibson delivered two talks on neurodegenerative diseases, one at the Hangzhou Qianjian International Rehabilitation Forum in Hangzhou, Zhejiang, China.

BNI Group Photo at Annual Retreat 2019
NEWS: 
Article
Faculty and staff reconnected and rejuvenated as they reviewed the Institute’s values and mission and discussed this year’s theme of bringing together the BNI team to help many.
Summer Class of 2019 group photo
NEWS: 
Article

Training the next generation of young talented scientists is a high priority at the Burke Neurological Institute.

NEWS: 
Social Media

June - July news highlights the unique ways that our Institute, scientists, and staff strive to bring hope to those living with neurological disabilities.

#SummerScience2019
NEWS: 
Article

Each year @BurkeNeuroSci invites extraordinary students from around the country to take part in cutting-edge medical research as part of a research team studying neural repair and restoration.

#SummerScience2019
NEWS: 
Article

Over 100 undergraduate students interested in pursuing a career in biomedical sciences applied for coveted spots in the Burke Neurological Institute’s Summer Science Research Program.

Summer Student Scholars Class of 2018
NEWS: 
Social Media

Burke Neurological Institute invites interested and qualified undergraduate students to apply to our Summer Science Research Program. The 10-week program will run from June through August 2019. Learn more >

Painting at the Annual Retreat 2018

NEWS: 
Article
Faculty and staff of the Burke Neurological Institute ventured off-site to attend a two-day Annual Retreat at the Skytop Lodge, a majestic lodge in the Pocono Mountains of Pennsylvania.
Annual Retreat 2017 Group Photo
NEWS: 
Article

Faculty and staff of Burke Medical Research Institute (BMRI) ventured off-site to attend a two-day Annual Retreat at the Skytop Lodge, a majestic lodge in the Pocono Mountains of Pennsylvania.

Summer Science Scholars of 2017
NEWS: 
Article

Each summer from June to August, Burke Medical Research Institute mentors the next generation of research scientists through the Summer Science Research Program.

Summer Science 2016
NEWS: 
Article

Each summer from June to August, Burke Medical Research Institute mentors the next generation of research scientists through the Summer Student Research Program.

NEWS: 
Article
Insightful, forward-looking presentation topics focused on neurological conditions, neuroscience research and therapeutic treatments.
Retreat Team 2015
NEWS: 
Article

Burke Medical Research Institute faculty and staff ventured out of the Institute to Skytop Lodge, a majestic lodge in the Pocono Mountains of Pennsylvania for the two-day Annual Retreat.